Recent Updates
Recently added Catalysts
ALNY Positive Sentiment

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Wednesday, September 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Alnylam Pharmaceuticals has announced that its management will present company overviews at two upcoming investor conferences. The Wells Fargo 21st Annual Healthcare Conference is scheduled for September 8, 2026, and the Morgan Stanley 24th Annual Global Healthcare Conference will take place on September 14, 2026. Both events will feature live audio webcasts.

Market Sentiment Analysis

POSITIVE FACTORS

  • Alnylam is actively engaging with investors.
  • The company is showcasing its RNAi therapeutics.
  • Upcoming presentations may enhance investor interest.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+25%
120-day peak, hindsight
Typical move
1.9%
average across 8 past catalysts
Lead asset
ALN-4324
Phase 1 · Obese or Overweight Healthy Volunteers

Full Press Release Details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following upcoming investor conferences: Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, 2026, at 8:45 AM ET in Everett, Massachusetts Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 10:00 AM ET in New York City A live audio webcast of each pre

Frequently Asked Questions

When is Alnylam presenting at the Wells Fargo Conference?

Alnylam will present at the Wells Fargo 21st Annual Healthcare Conference on September 8, 2026.

Where will the Morgan Stanley Conference be held?

The Morgan Stanley 24th Annual Global Healthcare Conference will take place in New York City.

What is the focus of Alnylam's presentations?

Alnylam will provide overviews of its RNAi therapeutics during the presentations.

Will the presentations be available online?

Yes, there will be live audio webcasts of each presentation.

ShareAdd on Google
Tags: ALNY Viatris Investor Conferences Healthcare Alnylam RNAi therapeutics investor conference webcast healthcare
Last updated: Sep 2, 2026

Biotech snapshot

Cash runway
$3308M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ALN-4324Phase 1
Obese or Overweight Healthy Volunteers →

Catalyst track record

+25%
best trade around ALNY's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for ALNY.

See every catalyst's timing & PoA →